chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Rash, Rash pruritic, Skin irritation
Clinical narrative: ON NOVEMBER 16, 2021 I WAS VACCINATED WITH THE THIRD DOSE FOR COVID 19 WITH PFIZER, ON DAY 16 I STARTED A RASH AND ITCHING ON THE LOWER BACK WHICH BY DECEMBER 6 WAS ALL OVER THE BODY IN THE FORM OF WEALS AND WITH A LOT OF ITCHING, THAT DAY I STARTED MY LONG JOURNEY THROUGH THE MEDICAL OFFICES, CHANGING MEDICATIONS, CREAMS AND SLEEPING PILLS AT EACH APPOINTMENT. THE DOCTORS DID NOT WORK UNTIL THEY PRESCRIBED ME TREATMENT WITH CORTIZONE, AFTER BLOOD TESTS AND A BIOPSY, WITH THE CORTIZONE UNDER THE INFLAMMATION BUT NOT THE ITCHING BECAUSE OF A CHANGE IN INSURANCE I COULD NOT GO BACK TO THE DERMATOLOGIST AND ON JANUARY 10 I RETURNED TO MY PRIMARY DOCTOR, THEY INJECTED ME AT THE CLINIC AND THEY CHANGED THE MEDICATION. I HAVE BEEN WITH THE ALLERGY FOR MORE THAN 2 MONTHS AND I WAS DISABLED FOR THREE WEEKS, I COULD NOT STAND HAVING CLOTHES ON 12/16/2021 BLOOD TESTS DIAGNOSTICS 12/16/2021 DR 12/21/2021; DR DERMATOLOGY 05/01/2021; DR; I COULD NOT RETURN TO A CONSULTATION WITH HER BECAUSE MY NEW INSURANCE DOES NOT COVER HER. I RETURNED TO MY PRIMARY DOCTOR 10/01/2021 DR. BECAUSE I CAME OUT POSITIVE FOR COVID I HAVE NOT BEEN ABLE TO RETURN TO A CONSULTATION. MODERNA'S VACCINES WERE APPLIED IN THE DOCTOR'S OFFICE BECAUSE DOCTOR WORKS THERE AT THAT TIME.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Biopsy, Blood test, Hypersensitivity, Inflammation, Paraesthesia
Clinical narrative: ON NOVEMBER 16, 2021 I WAS VACCINATED WITH THE THIRD DOSE FOR COVID 19 WITH PFIZER, ON DAY 16 I STARTED A RASH AND ITCHING ON THE LOWER BACK WHICH BY DECEMBER 6 WAS ALL OVER THE BODY IN THE FORM OF WEALS AND WITH A LOT OF ITCHING, THAT DAY I STARTED MY LONG JOURNEY THROUGH THE MEDICAL OFFICES, CHANGING MEDICATIONS, CREAMS AND SLEEPING PILLS AT EACH APPOINTMENT. THE DOCTORS DID NOT WORK UNTIL THEY PRESCRIBED ME TREATMENT WITH CORTIZONE, AFTER BLOOD TESTS AND A BIOPSY, WITH THE CORTIZONE UNDER THE INFLAMMATION BUT NOT THE ITCHING BECAUSE OF A CHANGE IN INSURANCE I COULD NOT GO BACK TO THE DERMATOLOGIST AND ON JANUARY 10 I RETURNED TO MY PRIMARY DOCTOR, THEY INJECTED ME AT THE CLINIC AND THEY CHANGED THE MEDICATION. I HAVE BEEN WITH THE ALLERGY FOR MORE THAN 2 MONTHS AND I WAS DISABLED FOR THREE WEEKS, I COULD NOT STAND HAVING CLOTHES ON 12/16/2021 BLOOD TESTS DIAGNOSTICS 12/16/2021 DR 12/21/2021; DR DERMATOLOGY 05/01/2021; DR; I COULD NOT RETURN TO A CONSULTATION WITH HER BECAUSE MY NEW INSURANCE DOES NOT COVER HER. I RETURNED TO MY PRIMARY DOCTOR 10/01/2021 DR. BECAUSE I CAME OUT POSITIVE FOR COVID I HAVE NOT BEEN ABLE TO RETURN TO A CONSULTATION. MODERNA'S VACCINES WERE APPLIED IN THE DOCTOR'S OFFICE BECAUSE DOCTOR WORKS THERE AT THAT TIME.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Pruritus, Rash
Clinical narrative: ON NOVEMBER 16, 2021 I WAS VACCINATED WITH THE THIRD DOSE FOR COVID 19 WITH PFIZER, ON DAY 16 I STARTED A RASH AND ITCHING ON THE LOWER BACK WHICH BY DECEMBER 6 WAS ALL OVER THE BODY IN THE FORM OF WEALS AND WITH A LOT OF ITCHING, THAT DAY I STARTED MY LONG JOURNEY THROUGH THE MEDICAL OFFICES, CHANGING MEDICATIONS, CREAMS AND SLEEPING PILLS AT EACH APPOINTMENT. THE DOCTORS DID NOT WORK UNTIL THEY PRESCRIBED ME TREATMENT WITH CORTIZONE, AFTER BLOOD TESTS AND A BIOPSY, WITH THE CORTIZONE UNDER THE INFLAMMATION BUT NOT THE ITCHING BECAUSE OF A CHANGE IN INSURANCE I COULD NOT GO BACK TO THE DERMATOLOGIST AND ON JANUARY 10 I RETURNED TO MY PRIMARY DOCTOR, THEY INJECTED ME AT THE CLINIC AND THEY CHANGED THE MEDICATION. I HAVE BEEN WITH THE ALLERGY FOR MORE THAN 2 MONTHS AND I WAS DISABLED FOR THREE WEEKS, I COULD NOT STAND HAVING CLOTHES ON 12/16/2021 BLOOD TESTS DIAGNOSTICS 12/16/2021 DR 12/21/2021; DR DERMATOLOGY 05/01/2021; DR; I COULD NOT RETURN TO A CONSULTATION WITH HER BECAUSE MY NEW INSURANCE DOES NOT COVER HER. I RETURNED TO MY PRIMARY DOCTOR 10/01/2021 DR. BECAUSE I CAME OUT POSITIVE FOR COVID I HAVE NOT BEEN ABLE TO RETURN TO A CONSULTATION. MODERNA'S VACCINES WERE APPLIED IN THE DOCTOR'S OFFICE BECAUSE DOCTOR WORKS THERE AT THAT TIME.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: ON NOVEMBER 16, 2021 I WAS VACCINATED WITH THE THIRD DOSE FOR COVID 19 WITH PFIZER, ON DAY 16 I STARTED A RASH AND ITCHING ON THE LOWER BACK WHICH BY DECEMBER 6 WAS ALL OVER THE BODY IN THE FORM OF WEALS AND WITH A LOT OF ITCHING, THAT DAY I STARTED MY LONG JOURNEY THROUGH THE MEDICAL OFFICES, CHANGING MEDICATIONS, CREAMS AND SLEEPING PILLS AT EACH APPOINTMENT. THE DOCTORS DID NOT WORK UNTIL THEY PRESCRIBED ME TREATMENT WITH CORTIZONE, AFTER BLOOD TESTS AND A BIOPSY, WITH THE CORTIZONE UNDER THE INFLAMMATION BUT NOT THE ITCHING BECAUSE OF A CHANGE IN INSURANCE I COULD NOT GO BACK TO THE DERMATOLOGIST AND ON JANUARY 10 I RETURNED TO MY PRIMARY DOCTOR, THEY INJECTED ME AT THE CLINIC AND THEY CHANGED THE MEDICATION. I HAVE BEEN WITH THE ALLERGY FOR MORE THAN 2 MONTHS AND I WAS DISABLED FOR THREE WEEKS, I COULD NOT STAND HAVING CLOTHES ON 12/16/2021 BLOOD TESTS DIAGNOSTICS 12/16/2021 DR 12/21/2021; DR DERMATOLOGY 05/01/2021; DR; I COULD NOT RETURN TO A CONSULTATION WITH HER BECAUSE MY NEW INSURANCE DOES NOT COVER HER. I RETURNED TO MY PRIMARY DOCTOR 10/01/2021 DR. BECAUSE I CAME OUT POSITIVE FOR COVID I HAVE NOT BEEN ABLE TO RETURN TO A CONSULTATION. MODERNA'S VACCINES WERE APPLIED IN THE DOCTOR'S OFFICE BECAUSE DOCTOR WORKS THERE AT THAT TIME.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Dry mouth, Immunisation, SARS-CoV-2 test, Vaccination failure
Clinical narrative: Booster; Tested positive for Covid; Tested positive for Covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (005570). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single, (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 04Dec2021, outcome "unknown" and all described as "Tested positive for Covid"; IMMUNISATION (medically significant), outcome "unknown", described as "Booster". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (04Dec2021) positive.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, Immunisation, SARS-CoV-2 test
Clinical narrative: Booster; Tested positive for Covid; Tested positive for Covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (005570). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single, (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 04Dec2021, outcome "unknown" and all described as "Tested positive for Covid"; IMMUNISATION (medically significant), outcome "unknown", described as "Booster". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (04Dec2021) positive.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: Covid test date: 03Jan2022; Covid test result: Positive; Covid test date: 03Jan2022; Covid test result: Positive; sore left arm; sore lymph nodes/armpit; sore lymph nodes/armpit; fever; fatigue; Dose 1 on 14Apr2021 and Dose 2 on 01May2021; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 01May2021 11:00 (Lot number: EW0175) at the age of 40 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Other medical history: Cat allergy" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Bnt162b2 (lot number: EEW0164, administration date: 14Apr2021, Administration time: 02:30 PM, dose number: 1, Vaccine location: Left arm), administration date: 14Apr2021, when the patient was 40 years old, for Covid-19 immunization, reaction(s): "sore left arm". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 03Jan2022, outcome "unknown" and all described as "Covid test date: 03Jan2022; Covid test result: Positive"; INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 01May2021 11:00, outcome "unknown", described as "Dose 1 on 14Apr2021 and Dose 2 on 01May2021"; PAIN IN EXTREMITY (non-serious) with onset 01May2021 17:30, outcome "recovered" (May2021), described as "sore left arm"; LYMPH NODE PAIN (non-serious), AXILLARY PAIN (non-serious) all with onset 01May2021 17:30, outcome "recovered" (May2021) and all described as "sore lymph nodes/armpit"; PYREXIA (non-serious) with onset 01May2021 17:30, outcome "recovered" (May2021), described as "fever"; FATIGUE (non-serious) with onset 01May2021 17:30, outcome "recovered" (May2021), described as "fatigue". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (03Jan2022) positive, notes: Nasal Swab; (21Oct2021) negative, notes: Nasal Swab. Therapeutic measures were not taken as a result of pain in extremity, lymph node pain, axillary pain, pyrexia, fatigue. Additional Information: Facility type vaccine was facility. No other vaccine in four weeks: No. Fatigue for 2 days after vaccine (May 1st to May 2nd); sore lymph nodes lasted about a week.  No follow-up attempts are possible. No further information is expected.  Follow-up (14Jan2022): Follow-up attempts are completed. No further information is expected.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Axillary pain, COVID-19, Drug ineffective, Fatigue, Inappropriate schedule of product administration
Clinical narrative: Covid test date: 03Jan2022; Covid test result: Positive; Covid test date: 03Jan2022; Covid test result: Positive; sore left arm; sore lymph nodes/armpit; sore lymph nodes/armpit; fever; fatigue; Dose 1 on 14Apr2021 and Dose 2 on 01May2021; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 01May2021 11:00 (Lot number: EW0175) at the age of 40 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Other medical history: Cat allergy" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Bnt162b2 (lot number: EEW0164, administration date: 14Apr2021, Administration time: 02:30 PM, dose number: 1, Vaccine location: Left arm), administration date: 14Apr2021, when the patient was 40 years old, for Covid-19 immunization, reaction(s): "sore left arm". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 03Jan2022, outcome "unknown" and all described as "Covid test date: 03Jan2022; Covid test result: Positive"; INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 01May2021 11:00, outcome "unknown", described as "Dose 1 on 14Apr2021 and Dose 2 on 01May2021"; PAIN IN EXTREMITY (non-serious) with onset 01May2021 17:30, outcome "recovered" (May2021), described as "sore left arm"; LYMPH NODE PAIN (non-serious), AXILLARY PAIN (non-serious) all with onset 01May2021 17:30, outcome "recovered" (May2021) and all described as "sore lymph nodes/armpit"; PYREXIA (non-serious) with onset 01May2021 17:30, outcome "recovered" (May2021), described as "fever"; FATIGUE (non-serious) with onset 01May2021 17:30, outcome "recovered" (May2021), described as "fatigue". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (03Jan2022) positive, notes: Nasal Swab; (21Oct2021) negative, notes: Nasal Swab. Therapeutic measures were not taken as a result of pain in extremity, lymph node pain, axillary pain, pyrexia, fatigue. Additional Information: Facility type vaccine was facility. No other vaccine in four weeks: No. Fatigue for 2 days after vaccine (May 1st to May 2nd); sore lymph nodes lasted about a week.  No follow-up attempts are possible. No further information is expected.  Follow-up (14Jan2022): Follow-up attempts are completed. No further information is expected.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Lymph node pain, Pain in extremity, Pyrexia, SARS-CoV-2 test
Clinical narrative: Covid test date: 03Jan2022; Covid test result: Positive; Covid test date: 03Jan2022; Covid test result: Positive; sore left arm; sore lymph nodes/armpit; sore lymph nodes/armpit; fever; fatigue; Dose 1 on 14Apr2021 and Dose 2 on 01May2021; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 01May2021 11:00 (Lot number: EW0175) at the age of 40 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Other medical history: Cat allergy" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Bnt162b2 (lot number: EEW0164, administration date: 14Apr2021, Administration time: 02:30 PM, dose number: 1, Vaccine location: Left arm), administration date: 14Apr2021, when the patient was 40 years old, for Covid-19 immunization, reaction(s): "sore left arm". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 03Jan2022, outcome "unknown" and all described as "Covid test date: 03Jan2022; Covid test result: Positive"; INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 01May2021 11:00, outcome "unknown", described as "Dose 1 on 14Apr2021 and Dose 2 on 01May2021"; PAIN IN EXTREMITY (non-serious) with onset 01May2021 17:30, outcome "recovered" (May2021), described as "sore left arm"; LYMPH NODE PAIN (non-serious), AXILLARY PAIN (non-serious) all with onset 01May2021 17:30, outcome "recovered" (May2021) and all described as "sore lymph nodes/armpit"; PYREXIA (non-serious) with onset 01May2021 17:30, outcome "recovered" (May2021), described as "fever"; FATIGUE (non-serious) with onset 01May2021 17:30, outcome "recovered" (May2021), described as "fatigue". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (03Jan2022) positive, notes: Nasal Swab; (21Oct2021) negative, notes: Nasal Swab. Therapeutic measures were not taken as a result of pain in extremity, lymph node pain, axillary pain, pyrexia, fatigue. Additional Information: Facility type vaccine was facility. No other vaccine in four weeks: No. Fatigue for 2 days after vaccine (May 1st to May 2nd); sore lymph nodes lasted about a week.  No follow-up attempts are possible. No further information is expected.  Follow-up (14Jan2022): Follow-up attempts are completed. No further information is expected.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Chills, Fatigue, Lymphadenopathy, Pyrexia
Clinical narrative: Covid test date: 03Jan2022; Covid test result: Positive; Covid test date: 03Jan2022; Covid test result: Positive; sore left arm; sore lymph nodes/armpit; sore lymph nodes/armpit; fever; fatigue; Dose 1 on 14Apr2021 and Dose 2 on 01May2021; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 01May2021 11:00 (Lot number: EW0175) at the age of 40 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Other medical history: Cat allergy" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Bnt162b2 (lot number: EEW0164, administration date: 14Apr2021, Administration time: 02:30 PM, dose number: 1, Vaccine location: Left arm), administration date: 14Apr2021, when the patient was 40 years old, for Covid-19 immunization, reaction(s): "sore left arm". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 03Jan2022, outcome "unknown" and all described as "Covid test date: 03Jan2022; Covid test result: Positive"; INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 01May2021 11:00, outcome "unknown", described as "Dose 1 on 14Apr2021 and Dose 2 on 01May2021"; PAIN IN EXTREMITY (non-serious) with onset 01May2021 17:30, outcome "recovered" (May2021), described as "sore left arm"; LYMPH NODE PAIN (non-serious), AXILLARY PAIN (non-serious) all with onset 01May2021 17:30, outcome "recovered" (May2021) and all described as "sore lymph nodes/armpit"; PYREXIA (non-serious) with onset 01May2021 17:30, outcome "recovered" (May2021), described as "fever"; FATIGUE (non-serious) with onset 01May2021 17:30, outcome "recovered" (May2021), described as "fatigue". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (03Jan2022) positive, notes: Nasal Swab; (21Oct2021) negative, notes: Nasal Swab. Therapeutic measures were not taken as a result of pain in extremity, lymph node pain, axillary pain, pyrexia, fatigue. Additional Information: Facility type vaccine was facility. No other vaccine in four weeks: No. Fatigue for 2 days after vaccine (May 1st to May 2nd); sore lymph nodes lasted about a week.  No follow-up attempts are possible. No further information is expected.  Follow-up (14Jan2022): Follow-up attempts are completed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Condition aggravated, Feeling abnormal, Headache, Product preparation issue
Clinical narrative: mild headache; booster; the vaccine, that they gave me was inactivated because it had been diluted in sterile water instead on normal saline; the vaccine, that they gave me was inactivated because it had been diluted in sterile water instead on normal saline; Shoulder pain; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 43 year-old female patient received bnt162b2 (BNT162B2), administration date 03Jan2022 08:40 (Lot number: FE3594) at the age of 43 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Type 1 diabetes" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE; LANTUS; HUMALOG. Vaccination history included: Bnt162b2 (Dose:1, have the same shoulder pain that I experienced with the first two vaccine), administration date: 21Dec2020, when the patient was 41 years old, for COVID-19 Immunization, reaction(s): "shoulder pain"; Bnt162b2 (Dose:2, have the same shoulder pain that I experienced with the first two vaccine), administration date: 18Jan2021, when the patient was 42 years old, for COVID-19 Immunization, reaction(s): "shoulder pain". The following information was reported: IMMUNISATION (non-serious) with onset 03Jan2022 08:40, outcome "unknown", described as "booster"; PRODUCT PREPARATION ERROR (non-serious), POOR QUALITY PRODUCT ADMINISTERED (non-serious) all with onset 03Jan2022, outcome "unknown" and all described as "the vaccine, that they gave me was inactivated because it had been diluted in sterile water instead on normal saline"; HEADACHE (non-serious) with onset 04Jan2022, outcome "unknown", described as "mild headache"; ARTHRALGIA (non-serious) with onset Jan2022, outcome "unknown", described as "Shoulder pain". Additional Information: The patient stated that she did not receive any vaccination within 4 weeks of the booster COVID-19 Vaccine. No investigation assessment. Consumer (Physician) stated, "I have a question. I am a physician who practices in withheld and I went in yesterday for my booster vaccine and that one fine then I got a call back from the person who had administered it, a nurse practitioner saying that the pharmacy had contacted them. Stating them, that the vaccine, that they gave me was inactivated because it had been diluted in sterile water instead on normal saline and they ask me to come back and re boost and they said, I could to do it to the same day and I declined because I wanted to see if I develop symptoms and I did not have a lot of familiarity with this happening and so, I guess I just wanted to know if diluting with in sterile water versus normal saline truly inactivate the vaccine or is it just a suboptimal vaccine. No treatments.  No follow-up attempts are possible. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Headache, Immunisation, Poor quality product administered, Product preparation error
Clinical narrative: mild headache; booster; the vaccine, that they gave me was inactivated because it had been diluted in sterile water instead on normal saline; the vaccine, that they gave me was inactivated because it had been diluted in sterile water instead on normal saline; Shoulder pain; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 43 year-old female patient received bnt162b2 (BNT162B2), administration date 03Jan2022 08:40 (Lot number: FE3594) at the age of 43 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Type 1 diabetes" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE; LANTUS; HUMALOG. Vaccination history included: Bnt162b2 (Dose:1, have the same shoulder pain that I experienced with the first two vaccine), administration date: 21Dec2020, when the patient was 41 years old, for COVID-19 Immunization, reaction(s): "shoulder pain"; Bnt162b2 (Dose:2, have the same shoulder pain that I experienced with the first two vaccine), administration date: 18Jan2021, when the patient was 42 years old, for COVID-19 Immunization, reaction(s): "shoulder pain". The following information was reported: IMMUNISATION (non-serious) with onset 03Jan2022 08:40, outcome "unknown", described as "booster"; PRODUCT PREPARATION ERROR (non-serious), POOR QUALITY PRODUCT ADMINISTERED (non-serious) all with onset 03Jan2022, outcome "unknown" and all described as "the vaccine, that they gave me was inactivated because it had been diluted in sterile water instead on normal saline"; HEADACHE (non-serious) with onset 04Jan2022, outcome "unknown", described as "mild headache"; ARTHRALGIA (non-serious) with onset Jan2022, outcome "unknown", described as "Shoulder pain". Additional Information: The patient stated that she did not receive any vaccination within 4 weeks of the booster COVID-19 Vaccine. No investigation assessment. Consumer (Physician) stated, "I have a question. I am a physician who practices in withheld and I went in yesterday for my booster vaccine and that one fine then I got a call back from the person who had administered it, a nurse practitioner saying that the pharmacy had contacted them. Stating them, that the vaccine, that they gave me was inactivated because it had been diluted in sterile water instead on normal saline and they ask me to come back and re boost and they said, I could to do it to the same day and I declined because I wanted to see if I develop symptoms and I did not have a lot of familiarity with this happening and so, I guess I just wanted to know if diluting with in sterile water versus normal saline truly inactivate the vaccine or is it just a suboptimal vaccine. No treatments.  No follow-up attempts are possible. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Congenital anomaly, Immunisation, Maternal exposure during pregnancy
Clinical narrative: Sever reaction including fever followed by miscarriage 3 days after vaccination; Sever reaction including fever followed by miscarriage 3 days after vaccination; booster dose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37 year-old female patient (pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 22Dec2021 12:15 (Batch/Lot number: unknown) at the age of 37 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. Date of last menstrual period: 04Nov2021. The patient was 6 weeks pregnant at the time of exposure to bnt162b2. The patient was 7 weeks pregnant at the event onset. The patient is expected to deliver a baby(s) on 11Aug2022. Concomitant medication(s) included: PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]. Vaccination history included: Bnt162b2 (Prev dose product=COVID 19,, prev dose brand=Pfizer ,, prev dose brand unknown=False,, prev dose lot number=Ew0178,, prev dose lot unknown=False,, prev dose administration date=, 02Jun2021,, prev dose dose number=2), administration date: 02Jun2021, when the patient was 36 years old, for COVID-19 immunization, reaction(s): "gestational period:7, 1st dose:12May2021,2nd dose:02Jun2021"; Bnt162b2 (Prev dose product=COVID 19,, prev dose brand=Pfizer ,, prev dose brand unknown=False,, prev dose lot number=Ew0183,, prev dose lot unknown=False,, prev dose administration date=, 12May2021,, prev dose dose number=1), administration date: 12May2021, when the patient was 36 years old, for COVID-19 immunization, reaction(s): "gestational period:7, 1st dose:12May2021,2nd dose:02Jun2021". The following information was reported: ABORTION SPONTANEOUS (congenital anomaly, medically significant), PYREXIA (congenital anomaly) all with onset 25Dec2021, outcome "not recovered" and all described as "Severe reaction including fever followed by miscarriage 3 days after vaccination"; IMMUNISATION (non-serious) with onset 22Dec2021 12:15, outcome "unknown", described as "booster dose". The event "severe reaction including fever followed by miscarriage 3 days after vaccination" and "severe reaction including fever followed by miscarriage 3 days after vaccination" was evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: negative. Therapeutic measures were not taken as a result of abortion spontaneous, pyrexia.  Additional information: If treatment ae: No, If Covid prior vaccination: No and If Covid tested post vaccination: Yes.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200056518 mother/baby case
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abortion spontaneous, Immunisation, Pyrexia, SARS-CoV-2 test
Clinical narrative: Sever reaction including fever followed by miscarriage 3 days after vaccination; Sever reaction including fever followed by miscarriage 3 days after vaccination; booster dose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37 year-old female patient (pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 22Dec2021 12:15 (Batch/Lot number: unknown) at the age of 37 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. Date of last menstrual period: 04Nov2021. The patient was 6 weeks pregnant at the time of exposure to bnt162b2. The patient was 7 weeks pregnant at the event onset. The patient is expected to deliver a baby(s) on 11Aug2022. Concomitant medication(s) included: PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]. Vaccination history included: Bnt162b2 (Prev dose product=COVID 19,, prev dose brand=Pfizer ,, prev dose brand unknown=False,, prev dose lot number=Ew0178,, prev dose lot unknown=False,, prev dose administration date=, 02Jun2021,, prev dose dose number=2), administration date: 02Jun2021, when the patient was 36 years old, for COVID-19 immunization, reaction(s): "gestational period:7, 1st dose:12May2021,2nd dose:02Jun2021"; Bnt162b2 (Prev dose product=COVID 19,, prev dose brand=Pfizer ,, prev dose brand unknown=False,, prev dose lot number=Ew0183,, prev dose lot unknown=False,, prev dose administration date=, 12May2021,, prev dose dose number=1), administration date: 12May2021, when the patient was 36 years old, for COVID-19 immunization, reaction(s): "gestational period:7, 1st dose:12May2021,2nd dose:02Jun2021". The following information was reported: ABORTION SPONTANEOUS (congenital anomaly, medically significant), PYREXIA (congenital anomaly) all with onset 25Dec2021, outcome "not recovered" and all described as "Severe reaction including fever followed by miscarriage 3 days after vaccination"; IMMUNISATION (non-serious) with onset 22Dec2021 12:15, outcome "unknown", described as "booster dose". The event "severe reaction including fever followed by miscarriage 3 days after vaccination" and "severe reaction including fever followed by miscarriage 3 days after vaccination" was evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: negative. Therapeutic measures were not taken as a result of abortion spontaneous, pyrexia.  Additional information: If treatment ae: No, If Covid prior vaccination: No and If Covid tested post vaccination: Yes.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200056518 mother/baby case
Age: 23.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: He was supposed to get flu shot and got 2nd booster instead. First booster on 12/3 was Pfizer. 2nd booster on 12/22 was Moderna.
Age: 23.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Extra dose administered, Interchange of vaccine products, Wrong product administered
Clinical narrative: He was supposed to get flu shot and got 2nd booster instead. First booster on 12/3 was Pfizer. 2nd booster on 12/22 was Moderna.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Peripheral swelling, Rash
Clinical narrative: her whole arm blew up, it wrapped around her arm and looked like cellulitis; she was tired; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (her whole arm blew up, it wrapped around her arm and looked like cellulitis) and FATIGUE (she was tired) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2021, the patient experienced PERIPHERAL SWELLING (her whole arm blew up, it wrapped around her arm and looked like cellulitis) and FATIGUE (she was tired). At the time of the report, PERIPHERAL SWELLING (her whole arm blew up, it wrapped around her arm and looked like cellulitis) and FATIGUE (she was tired) outcome was unknown.            No concomitant medication was provided by reporter.  The second shot, her whole arm blew up, it wrapped around her arm and looked like cellulitis. That was okay, she was tired and had normal stuff after get the vaccine.   No treatment drug was provided by reporter.   This case was linked to MOD-2022-456142, MOD-2022-452516 (Patient Link).
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Bell's palsy, Fatigue, Hypoaesthesia oral, Pyrexia
Clinical narrative: her whole arm blew up, it wrapped around her arm and looked like cellulitis; she was tired; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (her whole arm blew up, it wrapped around her arm and looked like cellulitis) and FATIGUE (she was tired) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2021, the patient experienced PERIPHERAL SWELLING (her whole arm blew up, it wrapped around her arm and looked like cellulitis) and FATIGUE (she was tired). At the time of the report, PERIPHERAL SWELLING (her whole arm blew up, it wrapped around her arm and looked like cellulitis) and FATIGUE (she was tired) outcome was unknown.            No concomitant medication was provided by reporter.  The second shot, her whole arm blew up, it wrapped around her arm and looked like cellulitis. That was okay, she was tired and had normal stuff after get the vaccine.   No treatment drug was provided by reporter.   This case was linked to MOD-2022-456142, MOD-2022-452516 (Patient Link).
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fatigue, Peripheral swelling
Clinical narrative: her whole arm blew up, it wrapped around her arm and looked like cellulitis; she was tired; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (her whole arm blew up, it wrapped around her arm and looked like cellulitis) and FATIGUE (she was tired) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2021, the patient experienced PERIPHERAL SWELLING (her whole arm blew up, it wrapped around her arm and looked like cellulitis) and FATIGUE (she was tired). At the time of the report, PERIPHERAL SWELLING (her whole arm blew up, it wrapped around her arm and looked like cellulitis) and FATIGUE (she was tired) outcome was unknown.            No concomitant medication was provided by reporter.  The second shot, her whole arm blew up, it wrapped around her arm and looked like cellulitis. That was okay, she was tired and had normal stuff after get the vaccine.   No treatment drug was provided by reporter.   This case was linked to MOD-2022-456142, MOD-2022-452516 (Patient Link).
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Chills, Nausea, Pain, Pyrexia, Tinnitus
Clinical narrative: ringing in my left ear; This spontaneous case was reported by a health care professional and describes the occurrence of TINNITUS (ringing in my left ear) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In December 2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In December 2020, the patient experienced TINNITUS (ringing in my left ear). At the time of the report, TINNITUS (ringing in my left ear) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment details were provided.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: ringing in my left ear; This spontaneous case was reported by a health care professional and describes the occurrence of TINNITUS (ringing in my left ear) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In December 2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In December 2020, the patient experienced TINNITUS (ringing in my left ear). At the time of the report, TINNITUS (ringing in my left ear) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment details were provided.
Age: 17.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Catheterisation cardiac, Chest pain, Ejection fraction normal, Electrocardiogram ST segment elevation, Troponin increased
Clinical narrative: pericarditis
Age: 17.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pericarditis
Clinical narrative: pericarditis
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity
Clinical narrative: arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0276208) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm soreness). At the time of the report, PAIN IN EXTREMITY (arm soreness) outcome was unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   Patient date of birth was unknown date in 1949.  No concomitant medications were reported.  No treatment medications were reported.   This case was linked to MOD-2022-455764, MOD-2022-455766 (Patient Link).
Age: 7.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product preparation error
Clinical narrative: On January 21, 2022 at 1630hrs, my daughter received her first dose of Covid shot.  After we came back home, I received a call from the vaccination site informing us that they gave my daughter an undiluted Covid-19 shot which is over the required dosage for her age. She did admit that it was a human error and that they have already reported it even before they called us. She advised us to monitor our daughter for 4 days and seek medical attention if there are any abnormalities on her condition.   On January 22, 2022 at 0830hrs, my daughter started to have fever, stomachache and pain, redness and swelling on her arm where she got the shot. We contacted her pediatrician and she advised us give her fever reducer, to apply cold compress on there arm to minimize the discomfort and to send her to ER if she have difficulty in breathing.
Age: 7.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Injection site erythema, Injection site swelling, Pain, Product preparation issue
Clinical narrative: On January 21, 2022 at 1630hrs, my daughter received her first dose of Covid shot.  After we came back home, I received a call from the vaccination site informing us that they gave my daughter an undiluted Covid-19 shot which is over the required dosage for her age. She did admit that it was a human error and that they have already reported it even before they called us. She advised us to monitor our daughter for 4 days and seek medical attention if there are any abnormalities on her condition.   On January 22, 2022 at 0830hrs, my daughter started to have fever, stomachache and pain, redness and swelling on her arm where she got the shot. We contacted her pediatrician and she advised us give her fever reducer, to apply cold compress on there arm to minimize the discomfort and to send her to ER if she have difficulty in breathing.
Age: 7.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: On January 21, 2022 at 1630hrs, my daughter received her first dose of Covid shot.  After we came back home, I received a call from the vaccination site informing us that they gave my daughter an undiluted Covid-19 shot which is over the required dosage for her age. She did admit that it was a human error and that they have already reported it even before they called us. She advised us to monitor our daughter for 4 days and seek medical attention if there are any abnormalities on her condition.   On January 22, 2022 at 0830hrs, my daughter started to have fever, stomachache and pain, redness and swelling on her arm where she got the shot. We contacted her pediatrician and she advised us give her fever reducer, to apply cold compress on there arm to minimize the discomfort and to send her to ER if she have difficulty in breathing.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Hyperhidrosis, Loss of consciousness
Clinical narrative: Client was sitting in the observation after receiving Pfizer booster. He stated he felt weak, stared sweating and unaware that he passed out. Client was adjustable and able to communicate with staff, accepted hydration and snacks. Vitals WNL 100/60,  68, 16, 97.6, 99% O2 sat on room air. Client over down for approximately 15 min before  On all Provider notified.    Client sitting up in chair. States he feels better. 118/70, 73, 99% on RA
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram pulmonary abnormal, Echocardiogram, Fibrin D dimer, Pulmonary embolism, Troponin
Clinical narrative: Bilateral PE
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Liver injury
Clinical narrative: Liver Damage.
Age: 41.0
Sex: F
Vaccine: FLU4
Symptoms: Bursitis, Injection site pain, Joint range of motion decreased, Magnetic resonance imaging, Neuralgia
Clinical narrative: 10/21- 10:43 am received vaccine-painful than normal but thought it would subside.  10/23-08:30am woke up earlier than normal on my day off, with extreme right shoulder pain and burning nerve pain down my whole arm. Swelling was notable and extremely painful.  10/25-called Dr office for first avail appointment 10/27/21. 10/27/21-diagnosed with Vaccine induced Bursitis 12/3-Orthopedic Surgeon seen--xray taken 10/29 -MRI 1/7/21-Cortisone shot given and PT order  1/11-PT for Right shoulder pain and loss of ROM Right shoulder  Treatment:   Ibprophen, Volteran topical gel, Ice and heat as needed  Outcomes:  Loss of range of motion, swelling and pain continue.
Age: 41.0
Sex: F
Vaccine: FLU4
Symptoms: Pain, Pain in extremity, Peripheral swelling, Sleep disorder, X-ray
Clinical narrative: 10/21- 10:43 am received vaccine-painful than normal but thought it would subside.  10/23-08:30am woke up earlier than normal on my day off, with extreme right shoulder pain and burning nerve pain down my whole arm. Swelling was notable and extremely painful.  10/25-called Dr office for first avail appointment 10/27/21. 10/27/21-diagnosed with Vaccine induced Bursitis 12/3-Orthopedic Surgeon seen--xray taken 10/29 -MRI 1/7/21-Cortisone shot given and PT order  1/11-PT for Right shoulder pain and loss of ROM Right shoulder  Treatment:   Ibprophen, Volteran topical gel, Ice and heat as needed  Outcomes:  Loss of range of motion, swelling and pain continue.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Pain
Clinical narrative: Pain in arm at site of 1st and 2nd shot. Sharp aching, inconsistent.
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event, Product preparation issue
Clinical narrative: patient came to the pharmacy on 1/21/22 around 2:30 pm to get his 2nd dose pediatric pfizer covid immunization. I forgot to dilute the bottle before drawing 0.2ml from it. And I inadvertently administered the undiluted dose to the patient.  I discovered the mistake around 4 pm, and I contacted pfizer immediately and obtained related clinical data from it. Then I contacted patient's mother and discussed with her in regards to the event, at the time I called, patient did not appear to have any adverse reaction. I told the mother that patient might have higher chance of getting adverse reaction including local injection reaction, fever, headache, flu-like symptoms, etc. Patient's mother will monitor patient during the weekend, and I will contact patient's mother on Monday (1/24/2022) to follow up
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Motor dysfunction, Syncope
Clinical narrative: Pure motor loss syncope
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Migraine, Muscle spasms, Nausea, Pain
Clinical narrative: I feel like I'm being burned alive. I have  nausea, severe pain, migraine and severe cramps. This has been going on all day.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram, Myocarditis, Pain
Clinical narrative: mild myocharditis; dull uncomfortable gripping feeling around heart under left breast spreading to my left shoulder and rib cage.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Pruritus
Clinical narrative: Received my vaccine on November 23, 2021 exactly 10 days later I experienced itchiness on my scalp chest neck palms and hands. Until this date I still have the symptoms which will now be seven weeks. Have been taking an anti-histamine which I have had side effects from so it has been very difficult for treatment. I am still the same no improvement.
Age: 21.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Electrocardiogram, Myocarditis, Troponin increased
Clinical narrative: Myocarditis. Treatment and outcome have yet to be determined at the time of this note.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site mass, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: I started with red spots on my right deltoid about 30 hours after vaccine administration. By 36 hours I started feeling my deltoid with lumps. The next day, my hives/redness was larger along with the swelling and tenderness of lumps. By the end of the 2nd day, my deltoid is very swollen/red/warm and causing pain and tingling to entire arm.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Paraesthesia, Urticaria
Clinical narrative: I started with red spots on my right deltoid about 30 hours after vaccine administration. By 36 hours I started feeling my deltoid with lumps. The next day, my hives/redness was larger along with the swelling and tenderness of lumps. By the end of the 2nd day, my deltoid is very swollen/red/warm and causing pain and tingling to entire arm.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Mechanical urticaria
Clinical narrative: Chronic dermatographia developed approximate 10-14 days after injection.  Affected area is body-wide.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Rash erythematous
Clinical narrative: Strange red almost rash like large mark appearing weeks after vaccine that matches ?Moderna rash?. Injection site still sore weeks later
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic, Sensitive skin, Urticaria
Clinical narrative: severe skin delay hypersensitivity that wakes up with itchy rashes and hives all over the body daily. Uncontrolled with over-the-counter allergy medications such as Allegra, and prescription such as  hydroxyzine 25 mg QD, prednisone 20 mg QD, triamcinolone 0.5%, and fluocinonide.